Keynote Financial Services’s Celularity CELU Stock Holding History

Keynote Financial Services’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39K	Buy	29,320 +4,000	+16%	+$5.06K	0.02%	173
2025 Q4	$28.1K	Buy	25,320 +840	+3%	+$1.51K	0.02%	168
2025 Q3	$50.7K	Buy	24,480 +1,000	+4%	+$2.8K	0.03%	163
2025 Q2	$46K	Sell	23,480 -1,543	-6%	-$2.81K	0.03%	161
2025 Q1	$43.3K	Hold	25,023	–	–	0.03%	157
2024 Q4	$52K	Buy	25,023 +11,863	+90%	+$28.3K	0.04%	151
2024 Q3	$39.1K	Hold	13,160	–	–	0.03%	152
2024 Q2	$41.2K	Sell	13,160 -2,406	-15%	-$8.35K	0.03%	145
2024 Q1	$81.4K	Buy	+15,566	New	+$64K	0.07%	142

Other funds holding CELU

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

Keynote Financial Services's CELU Position: Q1 2026 in Review

Keynote Financial Services increased its Celularity (CELU) stake by 16% in Q1 2026, buying an estimated $5.06K and bringing the position to 29,320 shares worth $39K. The position accounts for 0.02% of the portfolio, ranked #173.

Keynote Financial Services first reported a position in CELU in Q1 2024 and has held it in 9 quarters since. The position peaked at $81.4K in Q1 2024. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

Keynote Financial Services held 29,320 shares of Celularity worth $39K as of Q1 2026.
Keynote Financial Services bought 4,000 Celularity shares in Q1 2026, an estimated $5.06K.
Celularity made up 0.02% of Keynote Financial Services's portfolio in Q1 2026, its #173 holding.
Keynote Financial Services first reported a position in Celularity in Q1 2024 and has held it in 9 quarters since.
Keynote Financial Services's Celularity position peaked at $81.4K in Q1 2024.
38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.